Loading the session
Loading the session
Loading instrument
$252.08
+1.68%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:06 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 gain of 7.2% was 6.0× its average daily move of 1.2% over the past year, and its largest one-day gain since 15 May 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $247.91 was 12.8% above its 50-day average ($219.84) and 10.5% above its 200-day average ($224.31). It has closed above the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed below the 200-day on 25 Mar 2026, 155 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: +18.8% (SPY −1.6%, XLV +13.5%). 3 months: +6.5% (SPY −0.4%, XLV +15.5%). 1 year: +2.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: STE, SPY and XLV · as of 4 Nov 2026
$0.69 a share, payable 17 Dec 2026; unchanged from the previous payment (ex-date 4 Sep 2026).
Corporate actions record · as of 5 Nov 2026
The 14-session relative strength index closed at 72.6 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
May 11, 2023
+9.83%February 9, 2023
−10.89%August 3, 2022
−9.55%